KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Retained Earnings (2016 - 2025)

Novavax has reported Retained Earnings over the past 16 years, most recently at -$4.6 billion for Q4 2025.

  • Quarterly results put Retained Earnings at -$4.6 billion for Q4 2025, down 20149.78% from a year ago — trailing twelve months through Dec 2025 was -$4.6 billion (down 20149.78% YoY), and the annual figure for FY2025 was -$4.6 billion, down 20149.78%.
  • Retained Earnings for Q4 2025 was -$4.6 billion at Novavax, down from -$1.7 million in the prior quarter.
  • Over the last five years, Retained Earnings for NVAX hit a ceiling of $1.6 million in Q1 2025 and a floor of -$5.0 billion in Q1 2024.
  • Median Retained Earnings over the past 5 years was -$2.3 billion (2021), compared with a mean of -$2.1 billion.
  • Biggest five-year swings in Retained Earnings: crashed 315930.23% in 2022 and later surged 100.03% in 2025.
  • Novavax's Retained Earnings stood at -$1.4 million in 2021, then crashed by 315930.23% to -$4.3 billion in 2022, then fell by 12.75% to -$4.8 billion in 2023, then soared by 99.53% to -$22.6 million in 2024, then tumbled by 20149.78% to -$4.6 billion in 2025.
  • The last three reported values for Retained Earnings were -$4.6 billion (Q4 2025), -$1.7 million (Q3 2025), and -$458000.0 (Q2 2025) per Business Quant data.